SNPX Synaptogenix Accounting Capitalization

Public company logo of Synaptogenix (SNPX)

Bankruptcy risks dominate Synaptogenix, Inc. (SNPX) due to the depletion of funds following failed Alzheimer's drug trials, necessitating a revision of the R&D strategy. While demand for dementia treatment remains stable, the share price is influenced by the availability of capital for new offerings, which currently stands at 0.00. This daily price chart on GURU.Markets complements the picture of managing a micro-cap biotech where a team with a scientific background is focused on a single asset.

SNPX Synaptogenix Book Capitalization (07/04/2022 - 05/02/2026)

Metric breakdowns and analytics for Synaptogenix (SNPX)

- price and consensus price forecast:
Quote Chart Synaptogenix, Inc|SNPX - Consensus Target
- market capitalization data:
Market Capitalization Synaptogenix Inc.|SNPX - Total Company Value
- book capitalization data:
Equity per Share Synaptogenix|SNPX - Book Capitalization|Market-to-Book Ratio synaptogen.com|SNPX - Cumulative Company Assets
- debt and liquidity data:
Total Debt to Capital Synaptogenix, Inc.|SNPX - Long-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital Synaptogenix Inc.|SNPX - Company Debts|Debts to Book Value Synaptogenix Inc.
Summary company analysis:Synaptogenix, Inc - SNPX
Flagship merchandise of Synaptogenix Inc.

Book value capitalization measures the value of net assets minus liabilities, capturing the company's actual capital cushion. The current value of 0.00 on the book value of net assets chart reflects a rapid depletion of resources at Synaptogenix, Inc. (SNPX) due to a lack of revenue and high pre-commercial research costs, signaling a critical level of operational cash burn.

Who Synaptogenix, Inc. competes with

Biogen Idec (BIIB) - Net Asset Value|Company Net Assets Neurocrine Biosciences|RGC (regencellbioscience.com) - Accounting Capitalization|Company Book Value Axsome Therapeutics, Inc. (AXSM)|Accounting Capitalization ACADIA Pharma|Xenon Pharmaceuticals Inc - Book Capitalization|Total Stockholders' Equity Viking Therapeutics Corp VKTX|Company Net Assets SUPN (Supernus Pharmaceuticals)|catalystpharma.com - Book Capitalization|Company Book Value Denali Therapeutics Inc. (DNLI)|HRMY: Accounting Value of Company|Company Book Value BHVN|AMLX (Amylyx Corp) - Total Stockholders' Equity|TRVI: Company Book Value|Book Valuation of Business praxismedicines.com (PRAX)|Anavex Life Sciences Corp. - Company Net Assets|Total Stockholders' Equity CBLL (CeriBell Inc)|PRTA - Company Book Value|Accounting Capitalization Alector Inc. ALEC|Annexon, Inc. - Book Capitalization|OMER: Book Capitalization|Company Book Value Neurogene (NGNE)|Net Asset Value AC Immune S.A.|Voyager Pharma (VYGR) - Company Net Assets|Total Net Assets NMRA|Scilex Holding Company - Company Book Value|Total Stockholders' Equity tevogen.com (TVGN)|ACOG (Alpha Cognition Inc.) - Book Capitalization|Book Value of Business cogrx.com CGTX|IKT (Inhibikase) - Book Capitalization|SAVA: Total Stockholders' Equity|Company Book Value assertiotx.com|Coya Therapeutics (COYA) - Accounting Capitalization|VTGN: Book Capitalization|Book Valuation of Business Ovid Rx (OVID)|Company Net Assets Acumen Pharma ABOS|Accounting Capitalization CervoMed Corporation CRVO|Company Net Assets Alterity Therapeutics Limited|Accounting Value of Company Clene Inc CLNN|Book Capitalization PEPG (PepGen Corp)|JUNS: Book Valuation of Business|Company Book Value Relmada|Annovis Bio Corporation (ANVS) - Accounting Capitalization|Book Capitalization GRCE|Company Net Assets fireflyneuro.com (AIFF)|KLTO (Klotho Neurosciences Inc) - Company Net Assets|Book Valuation of Business NRSN (neurosense-tx.com)|Company Book Value RVPH|MetaVia Inc. - Book Valuation of Business|NeurAxis, Inc. (NRXS) - Company Book Value|HSDT: Accounting Capitalization|Company Book Value passagebio.com (PASG)|Net Asset Value Neuphoria Therapeutics|Company Net Assets Minerva Neurosciences Corp (NERV)|Accounting Capitalization ATHA|Company Book Value Addex Therapeutics ADXN|Accounting Capitalization alzamend.com (ALZN)|CYCN: Book Capitalization|PTIX - Total Stockholders' Equity|Pasithea - Company Net Assets|CRGT: Book Capitalization|Company Book Value Avenue Therapeutics ATXI|BCLI (brainstorm-cell.com) - Accounting Value of Company|Company Book Value CARA (Cara Therapeutics)|Total Stockholders' Equity CHRO|ELYM (Eliem Therapeutics) - Company Book Value|Book Valuation of Business intracellulartherapies.com ITCI|LBPH: Company Net Assets|marinuspharma.com - Total Stockholders' Equity|NKGen Biotech (NKGN) - Company Book Value|NRBO - Accounting Capitalization|SAGE: Book Capitalization|TRVN (Trevena Inc) - Book Capitalization|Company Book Value Vigil Neuroscience Inc. VIGL|Net Asset Value Anew Medical Inc. (WENA)|Company Net Assets Cerevel Therapeutics, Inc.